Five issuers uplisted from the OTC Markets to the NASDAQ or NYSE American in January 2018. Learn more about these OTC ‘graduates’ below.
Novume Solutions, Inc. (Nasdaq: NVMM)
On January 10, 2018, NVMM uplisted from the OTCQX to the NASDAQ Capital Market. Novume is a holding company of leading professional services firms. These firms aggregate highly-specialized, difficult-to-find talent and have the scale and systems to deploy that talent efficiently at the enterprise-level at a moment’s notice.
Nemaura Medical, Inc. (Nasdaq: NMRD)
On January 25, 2018, NMRD uplisted from the OTCQB to the Nasdaq Capital Market. Nemaura Medical is a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible glucose monitoring system for adjunctive use by persons with diabetes.
Collplant Holdings Ltd (Nasdaq: CLGN)
On January 31, 2018, NMRD uplisted form the OTCPINK to the Nasdaq. CollPlant is a regenerative medicine company leveraging its proprietary, plant-based recombinant human collagen (rhCollagen) technology for the development and commercialization of tissue repair products, initially for the orthobiologics, 3D Bio-printing of tissue and organs, and advanced wound care markets.
Avaya Holdings Corp. (NYSE: AVYA)
On January 17, 2018, AVYA uplisted from the OTCQX to the NYSE. Avaya enables the mission critical, real-time communication applications of the world’s most important operations. As the global leader in delivering superior communications experiences, Avaya provides the most complete portfolio of software and services for contact center and unified communications — offered on premises, in the cloud, or a hybrid.
Lithium Americas Corp. (NYSE: LAC)
On January 25, 2017, LAC uplisted from the OTCQX to the NYSE. Lithium Americas, together with SQM, is developing Cauchari-Olaroz, located in the Province of Jujuy, Argentina, through its 50% interest in Minera Exar.